Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases
Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases.
Related Articles
Improving health, one machine learning system at a time
MIT professor Marzyeh Ghassemi uses AI and machine learning to ensure health-care models are trained to be robust and fair.
What Are the Concerns of Patients with Aspirin-Exacerbated Respiratory Disease?
In this segment of the latest Lungcast episode, the characteristics of AERD and the concerns of patients were highlighted.
San Diego Discussion and Reception: Health and Our Oceans
6:00 p.m. – remarks Reception to Follow Hosted by the San Diego Program Committee
Relevant! Relevant! Relevant! At 50, Microsoft Is an AI Giant, Open-Source Lover, and as Bad as Ever
When Satya Nadella took over as CEO, the company was lumbering and uncool. He cleaned up a toxic culture, crafted the deal of the decade,…
This robot jumps and lands like a cat. It could be used to explore asteroids
Team in northeast China used artificial intelligence to train the robot to adjust its posture mid-air using its legs.
New report urges guidelines — and some restrictions — on stem cell-based embryo models
New report urges guidelines — and some restrictions — on stem cell-based embryo models.
In the MAHA-verse, ex-Bernie die-hards and conservative moms find a political home
MAHA supporters share a disturbing sense that the health care system and its regulators don’t have people’s best interests at heart
Trump taps biotech investor Jim O’Neill for HHS deputy secretary
O’Neill is close with billionaire Peter Thiel and worked on health care in the George W. Bush administration.
Cleveland Clinic Performs Its First Transorbital Neuroendoscopic Surgery
A minimally invasive surgical technique, which has been performed for the first time at Cleveland Clinic, provides patients with intracranial tumors an alternative to craniotomy.
Trump picks Stanford’s Jay Bhattacharya to lead NIH
Bhattacharya would be in charge of Trump’s bold goals to reform the NIH, which spends billions to fund medical research.
